St. John’s-based Nucliq Biologics, a specialist in gut microbiome science, has partnered with Medavie Blue Cross to provide its Gut Health program.
The program will combine registered dietician consultations with Nucliq’s Gutcheck or Gutcheck VIVO test kits in one program called Gut Health. It will be available to plan members through Medavie Blue Cross’s digital health services platform, Connected Care.
The collaboration improves access to microbiome-based testing as a tool to support digestion, immunity, metabolic health, and overall wellbeing, the company said in a press release.
“Gutcheck and Gutcheck VIVO were designed to give people a clear understanding of how their gut microbiome may be influencing their health,” said Dr. Nikitha Kendyala, company CEO and cancer biochemist.
“We see this as an important step in making microbiome science more accessible and more practical for everyday use."
Gutcheck is a microbiome test that analyzes the balance of bacteria in the gut and provides a personalized report with actionable guidance. The assessment identifies imbalances, highlights diet-related factors that may be contributing to symptoms, and offers specific, evidence-grounded nutrition and probiotic suggestions.
Gutcheck VIVO includes the full Gutcheck assessment along with additional insights tailored for women. The report provides a deeper understanding of the connections between gut health and hormonal regulation, skin health, bone health and other factors relevant to women’s health. It offers personalized, actionable food and probiotic recommendations.
The gut microbiome comprises the microbes such as bacteria, viruses and fungi present in a user’s intestines. GutCheck asseses microbiome by testing stool samples.
“You are what you eat, and what your microbes eat,” Co-Founder Purvikalyan Pallegar, a molecular biologist, told Entrevestor in a previous interview. “Feed your microbes, feed your bacteria."

